Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research Article

TPS, Thymidine Kinase, VEGF and Endostatin in Cytosol of Thyroid Tissue Samples

R. PIKNER, M. LUDVOKOVA, A. RYŠKA, I. KHOLOVA, L. HOLUBEC, O. TOPOLČAN, L. PECEN and J. FINEK
Anticancer Research May 2005, 25 (3A) 1517-1521;
R. PIKNER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pikner{at}fnplzen.cz
M. LUDVOKOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. RYŠKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. KHOLOVA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. HOLUBEC JR.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. TOPOLČAN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. PECEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. FINEK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

The aim of the study was to determine whether VEGF, TPS, TK or Endostatin determination in tissue cytosol may have some additional value in distinguishing among different types of thyroid lesions. These markers were chosen as representatives of the 2 main pathways (angiogenesis and proliferation) involved in thyroid diseases. VEGF is the most potent angiogenic promoter and Endostatin plays an opposing role. Thymidine kinase (TK) is a marker of DNA synthesis and TPS, cytokeratin 18 fragments, is a marker of the rate of proliferation. We determined qualitatively all four markers in tissue extracts: cytosol from 157 tissue specimens (93 goitre,12 Hashimoto's thyroiditis, 39 adenomas and 13 carcinomas). In 6 cases we were able to compare both normal and pathological tissue samples from a single patient. Statistically significant differences were found in the measured markers, but outliers were present in all groups. This fact does not permit their use in differential diagnosis. The highest levels of all markers were reached in adenomas, being higher than in carcinomas, probably explained by the higher overall metabolic rate in adenomas.

  • Thymidine kinase
  • TPS
  • VEGF
  • endostatin
  • thyroid gland
  • cytosol
  • Received May 27, 2004.
  • Accepted June 6, 2004.
  • Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 3A
1 May 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
TPS, Thymidine Kinase, VEGF and Endostatin in Cytosol of Thyroid Tissue Samples
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
TPS, Thymidine Kinase, VEGF and Endostatin in Cytosol of Thyroid Tissue Samples
R. PIKNER, M. LUDVOKOVA, A. RYŠKA, I. KHOLOVA, L. HOLUBEC, O. TOPOLČAN, L. PECEN, J. FINEK
Anticancer Research May 2005, 25 (3A) 1517-1521;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
TPS, Thymidine Kinase, VEGF and Endostatin in Cytosol of Thyroid Tissue Samples
R. PIKNER, M. LUDVOKOVA, A. RYŠKA, I. KHOLOVA, L. HOLUBEC, O. TOPOLČAN, L. PECEN, J. FINEK
Anticancer Research May 2005, 25 (3A) 1517-1521;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire